Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Ọmụmụ Ihe Ndị Dị Ugbu A

Mmerụ Ahụ nke Akwara Anya-02Mmerụ Ahụ nke Akwara Anya-02
01

Mmerụ Ahụ nke Akwara Anya-02

2024-07-17

Onye Ọrịa: Maazị Zhang

Okike: Nwoke
Afọ: 47

Mba: Ndị Chaịna

Nchọpụta ọrịa: Mmerụ Ahụ nke Akwara Anya-02

lee nkọwa zuru ezu
Mmerụ Ahụ nke Akwara Anya-01Mmerụ Ahụ nke Akwara Anya-01
02

Mmerụ Ahụ nke Akwara Anya-01

2024-07-17

Onye Ọrịa: Adulraheem

Okike: Nwoke
Afọ: 47

Mba:Saudi Arabia

Nchọpụta ọrịaMmerụ Ahụ nke Akwara Anya

lee nkọwa zuru ezu
Melanomas nke na-eme ka mmadụ nwee nsogbu -04Melanomas nke na-eme ka mmadụ nwee nsogbu -04
03

Melanomas nke na-eme ka mmadụ nwee nsogbu -04

2024-07-17

Onye Ọrịa:Maazị Li

Okike: Nwoke
Afọ: 45

Mba: Norwegian

Nchọpụta ọrịaMetastasis melanoma

lee nkọwa zuru ezu
Ọrịa kansa ovaria-03Ọrịa kansa ovaria-03
04

Ọrịa kansa ovaria-03

2024-07-17

Onye Ọrịa: Oriakụ K

Okike: Nwanyị
Afọ: 55

Mba: Norwegian

Nchọpụta ọrịa: Ọrịa kansa ovarian

lee nkọwa zuru ezu
Mkpụkpọ anya (na mbụ), nke na-esochi etuto imeju nke metastatic-02Mkpụkpọ anya (na mbụ), nke na-esochi etuto imeju nke metastatic-02
05

Mkpụkpọ anya (na mbụ), nke na-esochi etuto imeju nke metastatic-02

2024-07-17

Onye Ọrịa: Oriakụ Y

Okike: Nwanyị
Afọ: 40

Mba: Ndị Chaịna

Nchọpụta ọrịa: melanoma anya (na mbụ), nke na-esochi etuto imeju nke metastatic

lee nkọwa zuru ezu
Ọrịa kansa eriri afọ nke ọkwa nke anọ dị elu-01Ọrịa kansa eriri afọ nke ọkwa nke anọ dị elu-01
06

Ọrịa kansa eriri afọ nke ọkwa nke anọ dị elu-01

2024-07-17

Onye ọrịa:Amaghị aha

Okike: Nwoke

Afọ: Afọ iri anọ na ise

Mba: Ndị Chaịna

Nchọpụta: Ọrịa kansa eriri afọ nke dị elu nke IV

lee nkọwa zuru ezu
Ọrịa kansa prostate dị elu nke nwere ọtụtụ metastases ọkpụkpụ-05Ọrịa kansa prostate dị elu nke nwere ọtụtụ metastases ọkpụkpụ-05
07

Ọrịa kansa prostate dị elu nke nwere ọtụtụ metastases ọkpụkpụ-05

2024-07-17

Onye ọrịa:XXX

Okike: Nwoke

Afọ: 67

Mba: Qatar

Nchọpụta: Ọrịa kansa prostate dị elu nke nwere ọtụtụ metastases ọkpụkpụ

lee nkọwa zuru ezu
Ọrịa kansa endometrial nke ọkwa IVB-04Ọrịa kansa endometrial nke ọkwa IVB-04
08

Ọrịa kansa endometrial nke ọkwa IVB-04

2024-07-17

Onye ọrịa:XXX

Okike: Nwanyị

Afọ: 55

Mba: Norway

Nchọpụta: Ọrịa kansa endometrial nke oge IVB

lee nkọwa zuru ezu
Ọrịa ara aka ekpe nke nwere ọtụtụ metastases ọkpụkpụ (Oge nke IV), metastasis nke lymph node, na kansa lymphangitis n'ime akpa ume abụọ - 03Ọrịa ara aka ekpe nke nwere ọtụtụ metastases ọkpụkpụ (Oge nke IV), metastasis nke lymph node, na kansa lymphangitis n'ime akpa ume abụọ - 03
09

Ọrịa ara aka ekpe nke nwere ọtụtụ metastases ọkpụkpụ (Oge nke IV), metastasis nke lymph node, na kansa lymphangitis n'ime akpa ume abụọ - 03

2024-07-17

Onye ọrịa:Oriakụ W

Okike: Nwanyị

Afọ: 65

Mba: United Arab Emirates

Nchọpụta: Ọrịa ara aka ekpe nke nwere ọtụtụ metastases ọkpụkpụ (Oge nke IV), metastasis nke lymph node, na kansa lymphangitis n'ime akpa ume abụọ ahụ.

lee nkọwa zuru ezu
Ọrịa kansa akpa ume nke na-abụghị obere mkpụrụ ndụ (NSCLC)-02Ọrịa kansa akpa ume nke na-abụghị obere mkpụrụ ndụ (NSCLC)-02
10

Ọrịa kansa akpa ume nke na-abụghị obere mkpụrụ ndụ (NSCLC)-02

2024-07-17

Onye ọrịa:XXX

Okike: Nwoke

Afọ: 82

Mba: United Arab Emirates

Nchọpụta: Ọrịa kansa akpa ume nke na-abụghị obere mkpụrụ ndụ (NSCLC)

lee nkọwa zuru ezu
Ọrịa kansa akpa ume nke obere mkpụrụ ndụ metastatic-01Ọrịa kansa akpa ume nke obere mkpụrụ ndụ metastatic-01
11

Ọrịa kansa akpa ume nke obere mkpụrụ ndụ metastatic-01

2024-07-17

Onye ọrịa:XXX

Okike: Nwoke

Afọ: 65

Mba: Qatar

Nchọpụta: Ọrịa kansa akpa ume nke obere mkpụrụ ndụ metastatic

lee nkọwa zuru ezu
Ọrịa lymphoma B-cell buru ibu (DLBCL)-04Ọrịa lymphoma B-cell buru ibu (DLBCL)-04
12

Ọrịa lymphoma B-cell buru ibu (DLBCL)-04

2024-07-16

Onye ọrịa:Maazị Li

Okike: Nwoke

Afọ: 64

Mba: Ndị Chaịna

Nchọpụta: Ọrịa lymphoma B-cell buru ibu (DLBCL)

lee nkọwa zuru ezu